Aligos Therapeutics (ALGS) Q2 2026 Earnings Report

482 Followers

ALGS Q2 2026 EPS Results

Actual EPS-$0.14

Consensus EPS-$1.09

Beat/MissBeat by +$0.95

One Year Ago EPS-$1.53

Actual Revenue$27.78M

Expected Revenue$24.68M

Beat/MissBeat by +$3.10M

YoY Revenue Growth+2778.55%

QuarterQ2 2026

Date08/06/2026

TimeBefore Open

Conference CallThursday, August 6, 2026

ALGS Upcoming Earnings

Aligos Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 11, 2027	2026 (Q4)	- / -	-1.91	―
Aug 06, 2026	2026 (Q2)	-1.09 / -0.14	-1.53	90.85% (+1.39)
May 07, 2026	2026 (Q1)	-2.21 / -2.21	-2.11	-4.74% (-0.10)
Mar 05, 2026	2025 (Q4)	-2.49 / -1.91	-13.08	85.40% (+11.17)
Nov 06, 2025	2025 (Q3)	-1.90 / -3.04	-3.07	0.98% (+0.03)
Aug 06, 2025	2025 (Q2)	-2.36 / -1.53	0.75	-304.00% (-2.28)
May 06, 2025	2025 (Q1)	-2.98 / -2.11	-5.5	61.64% (+3.39)
Mar 10, 2025	2024 (Q4)	-2.50 / -13.08	-5.5	-137.82% (-7.58)
Nov 06, 2024	2024 (Q3)	-2.16 / -3.07	-10.25	70.05% (+7.18)
Aug 06, 2024	2024 (Q2)	-4.00 / 0.75	-10.75	106.98% (+11.50)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed